SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PINNACLE ASSOCIATES LTD | 176,017 | $3,622,430 | 0.07% |
| Virtus ETF Advisers LLC | 5,240 | $107,839 | 0.06% |
| ALGERT GLOBAL LLC | 56,690 | $1,167 | 0.06% |
| Rafferty Asset Management, LLC | 411,904 | $8,476,984 | 0.05% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 12,400 | $255,192 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,231 | $8,051,534 | 0.05% |
| Hudson Bay Capital Management LP | 550,000 | $11,319,000 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 11,066 | $227,738 | 0.04% |
| Inspire Investing, LLC | 15,049 | $309,708 | 0.04% |
| Verition Fund Management LLC | 145,300 | $2,990,274 | 0.04% |
| Candriam S.C.A. | 227,000 | $4,671,660 | 0.03% |
| E Fund Management Co., Ltd. | 21,160 | $435 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 6,572,260 | $135,257,109 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 18,042 | $371,304 | 0.02% |
| EASTERLY INVESTMENT PARTNERS LLC | 10,000 | $205,800 | 0.02% |
| Clarius Group, LLC | 10,994 | $226,257 | 0.02% |
| Schonfeld Strategic Advisors LLC | 129,419 | $2,663,443 | 0.02% |
| Caption Management, LLC | 60,000 | $1,234,800 | 0.02% |
| DEUTSCHE BANK AG\ | 1,028,301 | $21,162,435 | 0.01% |
| FMR LLC | 7,696,055 | $158,384,813 | 0.01% |
External links
This page lists SAGE THERAPEUTICS INC's shareholders in Q3 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.